Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies. (MODISC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01694134|
Recruitment Status : Recruiting
First Posted : September 26, 2012
Last Update Posted : June 1, 2016
|Condition or disease||Intervention/treatment||Phase|
|Low Back Pain Lumbago Modic I Discopathy||Drug: Hydrocortancyl. Drug: Lidocaine||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.|
|Study Start Date :||July 2012|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||June 2017|
Active Comparator: Corticoids
A group of patients will receive an intradiscal injection of Hydrocortancyl.
Patients will receive an intradiscal injection of hydrocortancyl.
Sham Comparator: Local anaesthetic
A group of patients will receive an intradiscal injection of Lidocaine.
- Pain assessment [ Time Frame: 6 months ]The pain will be assessed by the visual analog scale (VAS).
- Quality of life assessment [ Time Frame: 6 months ]Quality of life will be assessed by the self-questionnaire SF-36.
- Consumption of analgesics and NSAIDs assessment [ Time Frame: 6 months ]
- Specific low back pain parameters assessment [ Time Frame: 6 months ]Low back pain parameters will be assessed by the Dallas scale and the Oswestry scale.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694134
|Contact: Isabelle Tavares, MD||+334 67 33 88 email@example.com|
|Hospital University of Montpellier||Recruiting|
|Montpellier, France, 34000|
|Contact: Isabelle Tavares, MD +334 67 33 88 26 firstname.lastname@example.org|
|Principal Investigator: Isabelle Tavares, MD|